N687JL

This airframe, registered as N687JL, is a 2015-built Cessna Citation CJ4 (525C) with serial number 525C0202 manufactured by Textron Aviation Inc. (Cessna). The aircraft is owned by ATI AVIATION LLC, an LLC headquartered in Middletown, CT, US, and operates with a US registration. The airframe's market valuation is listed at $8,000,000, reflecting its late-model build year, typical avionics fit and twin Williams engines. No further public registry actions or transfers are recorded in the supplied data.

This specific CJ4 airframe is configured to accommodate 10 seats, consistent with the type’s single-class light business jet layout emphasizing executive transport and charter missions. The installed avionics package is the Collins Pro Line 21, typical for CJ4 series aircraft of this vintage, enabling modern flight management, integrated autopilot and approaches appropriate for commercial and private operations. With a cruise of 451 knots and a range of 2,165 nautical miles, the aircraft is well suited to transcontinental U.S. missions and shorter international hops from its home base in Middletown, CT, US under the ownership of ATI AVIATION LLC. Maintenance considerations for this airframe focus on twin Williams FJ44-4A engine inspections and avionics support for the Pro Line 21 suite; routine heavy checks, ADS-B and RVSM compliance are typical for continued commercial or fractional operation.

The Cessna Citation CJ4 (525C) occupies the light jet niche for operators seeking high cruise speeds and transcontinental capability without stepping into midsize category costs. Its competition includes light-to-midsize offerings that prioritize speed and range; buyers often compare performance and operating economics against similar models from Embraer and Bombardier. Resale and maintenance considerations for this airframe are influenced by its 2015 build year, the commonality of the FJ44-4A engine, and the Collins Pro Line 21 avionics—attributes that tend to support stable charter demand and predictable maintenance pathways.